A newly discovered amino acid, 5-S-cysteinyldopa, present in the urine of healthy subjects is excreted in pathological amounts in many patients suffering from melanoma metastases. Increased excretion of 5-S-cysteinyldopa may be observed before metastases become clinically evident. Determination of 5-S-cysteinyldopa is superior to determination of dopa+dopamine in the diagnosis of melanoma metastases.
No takes yet. Share an insight, caveat, or question.
Agrup et al. (1977) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: